InvestSMART

Botanix Pharmaceuticals Ltd (ASX: BOT) - Announcements

Current share price for BOT : $0.009 0.001 (10%)+

ASX company news and announcements for Botanix Pharmaceuticals Ltd (BOT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Botanix Pharmaceuticals Ltd (BOT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Botanix Pharmaceuticals Ltd (BOT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Botanix Pharmaceuticals Ltd (BOT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Investor Presentation and Video 31 Jan 2023 9:39AM $0.056 $0.009 fallen by 83.93%
$25 Appendix 4C - Quarterly 31 Jan 2023 9:23AM $0.056 $0.009 fallen by 83.93%
$25 Botanix attends JP Morgan Healthcare Conference 9 Jan 2023 9:32AM $0.060 $0.009 fallen by 85%
$25 Change of Director's Interest Notice * 5 4 Jan 2023 10:08AM $0.053 $0.009 fallen by 83.02%
$25 Notification regarding unquoted securities - BOT 4 Jan 2023 9:59AM $0.052 $0.009 fallen by 82.69%
$25 Change of Director's Interest Notice *5 14 Dec 2022 6:45PM $0.058 $0.009 fallen by 84.48%
$25 Notice under Section 708A(5)(e) of the Corporations Act 12 Dec 2022 2:58PM $0.059 $0.009 fallen by 84.75%
$25 Application for quotation of securities - BOT 12 Dec 2022 2:46PM $0.059 $0.009 fallen by 84.75%
$25 Notification regarding unquoted securities - BOT 12 Dec 2022 2:36PM $0.059 $0.009 fallen by 84.75%
$25 Confirmation Sofpironium Bromide NDA Formally Under Review 8 Dec 2022 9:35AM $0.060 $0.009 fallen by 85%
$25 Application for quotation of securities - BOT 30 Nov 2022 11:57AM $0.062 $0.009 fallen by 85.48%
$25 Notice Under Section 708A(5)(e) of the Corporations Act 2001 29 Nov 2022 9:24AM $0.063 $0.009 fallen by 85.71%
$25 Placement Completion and Results of Share Purchase Plan 29 Nov 2022 9:15AM $0.063 $0.009 fallen by 85.71%
$25 Application for quotation of securities - BOT 29 Nov 2022 9:03AM $0.063 $0.009 fallen by 85.71%
$25 Results of Meeting 23 Nov 2022 5:14PM $0.063 $0.009 fallen by 85.71%
$25 Presentation Annual General meeting 23 Nov 2022 11:46AM $0.063 $0.009 fallen by 85.71%
$25 Webinar - initial market research Sofpironium Bromide 18 Nov 2022 9:26AM $0.063 $0.009 fallen by 85.71%
$25 Becoming a substantial holder from IFL 10 Nov 2022 4:27PM $0.059 $0.009 fallen by 84.75%
$25 Share Purchase Plan Opens 9 Nov 2022 9:31AM $0.062 $0.009 fallen by 85.48%
$25 Cleansing Notice - Placement and Share Purchase Plan 7 Nov 2022 9:33AM $0.063 $0.009 fallen by 85.71%
$25 Application for quotation of securities - BOT 7 Nov 2022 9:27AM $0.063 $0.009 fallen by 85.71%
$25 Data Presentation-American Society of Nephrology Conference 4 Nov 2022 9:31AM $0.063 $0.009 fallen by 85.71%
$25 Letter/ Supplementary Notice of AGM/Proxy Form 3 Nov 2022 7:31PM $0.063 $0.009 fallen by 85.71%
$25 Proposed issue of securities - BOT 31 Oct 2022 10:23AM $0.063 $0.009 fallen by 85.71%
$25 Proposed issue of securities - BOT 31 Oct 2022 10:23AM $0.063 $0.009 fallen by 85.71%

326 - 350 of 726 results

Page 14 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.